机构:[1]Tianjin Med Univ Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China[2]Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Ophthalmol, Beijing, Peoples R China[3]Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China[4]Xiamen Univ, Dept Ocular Trauma, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China[5]Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China[6]Peking Univ Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China[7]Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai, Peoples R China[8]Ningbo Eye Hosp, Dept Ophthalmol, Ningbo, Zhejiang, Peoples R China[9]Cent South Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Peoples R China[10]Sun Yat sen Univ, Dept Ophthalmol, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China[11]Sun Yat sen Univ, Zhongshan Sch Med, Dept Genet & Biomed Informat, Shantou, Guangdong, Peoples R China[12]Tianjin Med Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr M, Southwest Hosp, Dept Ophthalmol, Chongqing, Peoples R China[13]Fourth Mil Med Univ, Xijing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian, Shaanxi, Peoples R China[14]Gen Hosp Eastern Theater Command, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China[15]Wenzhou Med Univ, Eye Hosp, Natl Clin Res Ctr Ocular Dis, Wenzhou, Zhejiang, Peoples R China[16]Heilongjiang Prov Ophthalmol Hosp, Dept Ocular Trauma, Harbin, Heilongjiang, Peoples R China[17]Xian Peoples Hosp, Xian Hosp 4, Dept Ophthalmol, Xian, Shaanxi, Peoples R China[18]Peking Univ Third Hosp, Dept Ophthalmol, Beijing Key Lab Restorat Damaged Ocular Nerve, Beijing, Peoples R China[19]Xining First Peoples Hosp, Dept Ophthalmol, Xining, Qinghai, Peoples R China[20]Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China四川省人民医院[21]Wuhan Univ, Eye Ctr, Renmin Hosp, Wuhan, Hubei, Peoples R China[22]Tianjin Med Univ, Lab Mol Ophthalmol, Tianjin, Peoples R China[23]Tianjin Medical University Eye Hospital, Eye Institute & School of Optometry and Ophthalmology, Tianjin, China[24]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China [25]Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, Hainan, China [26]Center for Precision Medicine and Department of Genetics and Biomedical Informatics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China [27]Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China [28]School of Medicine, Nankai University, Tianjin, China
BackgroundThe visual outcome of open globe injury (OGI)-no light perception (NLP) eyes is unpredictable traditionally. This study aimed to develop a model to predict the visual outcomes of vitrectomy surgery in OGI-NLP eyes using a machine learning algorithm and to provide an interpretable system for the prediction results. MethodsClinical data of 459 OGI-NLP eyes were retrospectively collected from 19 medical centres across China to establish a training data set for developing a model, called 'VisionGo', which can predict the visual outcome of the patients involved and compare with the Ocular Trauma Score (OTS). Another 72 cases were retrospectively collected and used for human-machine comparison, and an additional 27 cases were prospectively collected for real-world validation of the model. The SHapley Additive exPlanations method was applied to analyse feature contribution to the model. An online platform was built for real-world application. ResultsThe area under the receiver operating characteristic curve (AUC) of VisionGo was 0.75 and 0.90 in previtrectomy and intravitrectomy application scenarios, which was much higher than the OTS (AUC=0.49). VisionGo showed better performance than ophthalmologists in both previtrectomy and intravitrectomy application scenarios (AUC=0.73 vs 0.57 and 0.87 vs 0.64). In real-world validation, VisionGo achieved an AUC of 0.60 and 0.91 in previtrectomy and intravitrectomy application scenarios. Feature contribution analysis indicated that wound length-related indicators, vitreous status and retina-related indicators contributed highly to visual outcomes. ConclusionsVisionGo has achieved an accurate and reliable prediction in visual outcome after vitrectomy for OGI-NLP eyes.
基金:
National Key R&D Program of China (grants
2021YFC2401404) and National Natural Science Foundation of China (grants
81830026 and 82020108007).
第一作者机构:[1]Tianjin Med Univ Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Tianjin Med Univ Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China[3]Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China[22]Tianjin Med Univ, Lab Mol Ophthalmol, Tianjin, Peoples R China[24]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China [25]Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, Hainan, China [26]Center for Precision Medicine and Department of Genetics and Biomedical Informatics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China [27]Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China [28]School of Medicine, Nankai University, Tianjin, China[*1]Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China[*2]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China[*3]Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
推荐引用方式(GB/T 7714):
Meng Xiangda,Wang Qihua,Chen Song,et al.An interpretable model predicts visual outcomes of no light perception eyes after open globe injury[J].BRITISH JOURNAL OF OPHTHALMOLOGY.2024,108(2):285-293.doi:10.1136/bjo-2022-322753.
APA:
Meng, Xiangda,Wang, Qihua,Chen, Song,Zhang, Shijie,Yu, Jinguo...&Yan, Hua.(2024).An interpretable model predicts visual outcomes of no light perception eyes after open globe injury.BRITISH JOURNAL OF OPHTHALMOLOGY,108,(2)
MLA:
Meng, Xiangda,et al."An interpretable model predicts visual outcomes of no light perception eyes after open globe injury".BRITISH JOURNAL OF OPHTHALMOLOGY 108..2(2024):285-293